Form 8-K Viridian Therapeutics, For: Jun 26

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. NXPI
4. SPY
5. BA
6. STX
7. NOW
8. GOOGL
9. CSGP
10. LSTR

Go back to Form 8-K Viridian Therapeutics, For: Jun 26

Viridian Therapeutic (VRDN) PT Raised to $43 at Wedbush

June 29, 2026 12:25 PM EDT

Wedbush analyst Laura Chico raised the price target on Viridian Therapeutic (NASDAQ: VRDN) to $43.00 (from $32.00) while maintaining a Outperform rating.

The analyst comments "Remain Outperform rated on VRDN, new $43 target. Most notable on the VRDN investor call, management confirmed the Lumvoa price... More

William Blair on Viridian Therapeutic (VRDN): 'We came away from the call incrementally more confident'

June 29, 2026 12:25 PM EDT

William Blair analyst Lachlan Hanbury-Brown reiterated an Outperform rating on Viridian Therapeutic (NASDAQ: VRDN)

The analyst comments "On Monday, June 29, Viridian hosted a call to discuss the approval and commercial launch of Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED).... More